Literature DB >> 33626865

Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T-cell leukemia.

Greta Forlani1, Mariam Shallak1, Alessandra Tedeschi1, Ilaria Cavallari2, Ambroise Marçais3, Olivier Hermine3, Roberto S Accolla4.   

Abstract

Adult T-cell leukemia-lymphoma (ATL), is a highly malignant T-cell neoplasm caused by human T-cell leukemia virus type 1 (HTLV-1), characterized by a poor prognosis. Two viral proteins, Tax-1 and HBZ play important roles in the pathogenesis of ATL. While Tax-1 can be found in both cytoplasm and nucleus of HTLV-1 infected patients, HBZ is exclusively localized in the cytoplasm of HTLV-1 asymptomatic carriers and patients with chronic neurologic disease HAM/TSP, and only in the nucleus of ATL cell lines, suggesting that the nuclear localization of HBZ can be a hallmark of neoplastic transformation. To clarify this crucial point, here we investigated in detail the pattern of HBZ expression in ATL patients. We made use of our monoclonal antibody 4D4-F3, that at present is a uniquely reported reagent, among the few described, able to detect endogenous HBZ by immunofluorescence and confocal microscopy in cells from asymptomatic carriers, HAM/TSP and ATL patients. We found that HBZ localizes both in the cytoplasm and in the nucleus of cells of ATL patients irrespective of their clinical status, with a strong preference for the cytoplasmic localization. Also Tax-1 localized in both compartments. As HBZ is exclusively localized in the cytoplasm in asymptomatic carriers and in non-neoplastic pathologies, this finding shows that neoplastic transformation consequent to HTLV-1 infection is accompanied and associated with the capacity of HBZ to translocate to the nucleus, which suggests a role of cytoplasmic-to-nuclear translocation in HTLV-1-mediated oncogenesis.

Entities:  

Year:  2021        PMID: 33626865     DOI: 10.3324/haematol.2020.272468

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  5 in total

Review 1.  Regulation of HTLV-1 transformation.

Authors:  Kyle J Ernzen; Amanda R Panfil
Journal:  Biosci Rep       Date:  2022-03-31       Impact factor: 3.840

2.  Reflections on Some of the Exceptional Features of HTLV-1 and HTLV-1 Research: A Perspective.

Authors:  Robert C Gallo; Yutaka Tagaya
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

Review 3.  The Road to HTLV-1-Induced Leukemia by Following the Subcellular Localization of HTLV-1-Encoded HBZ Protein.

Authors:  Roberto S Accolla
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

4.  The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing.

Authors:  Mariam Shallak; Tiziana Alberio; Mauro Fasano; Maria Monti; Ilaria Iacobucci; Julien Ladet; Franck Mortreux; Roberto S Accolla; Greta Forlani
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

Review 5.  Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia.

Authors:  Hiba El Hajj; Ali Bazarbachi
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.